Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

CandlesBACKEDSECURITIES Jul. 31 at 12:28 AM

$PFE can we talk about $31? Touchy subject? 😂

0 · Reply

cmhuff Jul. 30 at 11:47 PM

$PFE Sold another put here. Maybe I'm just dumb but I like the dividend and cash flow from selling covered calls

0 · Reply

CandlesBACKEDSECURITIES Jul. 30 at 11:00 PM

$PFE is this going to zero? What the fuck happened to its market cap?

2 · Reply

CandlesBACKEDSECURITIES Jul. 30 at 10:58 PM

$PFE who is the head Pfizer nerd in charge here?

0 · Reply

DidYouReadThis Jul. 30 at 7:52 PM

$NVS $JNJ $PFE $BAYRY

0 · Reply

Stockman824 Jul. 30 at 7:28 PM

$ABBV $LLY $MRK $PFE $VKTX I agree 100% and as @ihsvenoidea will back me up. We were in Arena Pharmaceuticals with quite possibly THE WORST Slimiest CEO ever but we got bought out for 100 by Pfizer after a 1/10 rs he was truly awful but Arenas SCIENCE was BEST IN CLASS by far. It always comes down to the SCIENCE. Hopefully we get a really strong BP partnership and they take over a lot of the calls. We can EASILY become a 500+ company in a few years

0 · Reply

Micheal_Pothead Jul. 30 at 7:12 PM

$PFE can’t wait for them to kill it in the last hour

1 · Reply

nimii Jul. 30 at 6:39 PM

$PFE 😡

0 · Reply

biolover Jul. 30 at 6:23 PM

$VKTX SP will partially correct by last hour. It is becoming obvious. $LLY TZP will generate more than whole $PFE and $MRK this year. Likely more than whole $ABBV BL stupidity on ECs will not matter long term.

0 · Reply

inv1ncible Jul. 30 at 5:54 PM

$PFE red on a green day. That makes sense🙄

0 · Reply

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

2026-07-30T11:03:18.000Z - 14 hours ago

Pfizer says LITFULO studies meet co-primary endpoints

Jul 30, 2026, 6:45 AM EDT - 15 hours ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

2026-07-29T20:42:19.000Z - 1 day ago

EC authorizes Pfizer, BioNTech XFG-adapted COVID-19 vaccine in EU

BNTX

Jul 29, 2026, 4:30 PM EDT - 1 day ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 8 days ago

Pfizer's prostate cancer drug combination gets US FDA priority review

2026-07-22T20:40:37.000Z - 8 days ago

FDA grants priority review for Pfizer’s Talzena plus Xtandi

Jul 22, 2026, 4:30 PM EDT - 8 days ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 9 days ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 14 days ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

2026-07-16T11:45:21.000Z - 14 days ago

Arbutus initiates patent infringement actions against Pfizer, BioNTech

ABUS BNTX ROIV

2026-07-13T12:26:33.000Z - 17 days ago

Pfizer price target lowered to $30 from $34 at BMO Capital

2026-07-13T11:06:16.000Z - 17 days ago

Pfizer price target lowered to $35 from $36 at Guggenheim

2026-07-10T15:30:20.000Z - 20 days ago

Pfizer, Astellas announces FDA approval of PADCEV plus Keytruda in MIBC

MRK

Jul 10, 2026, 11:23 AM EDT - 20 days ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

2026-07-10T10:30:21.000Z - 20 days ago

Pfizer price target lowered to $26 from $27 at BofA

Jul 6, 2026, 10:00 AM EDT - 24 days ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 4 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 4 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 5 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 5 weeks ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 5 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 5 weeks ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 5 weeks ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 5 weeks ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 5 weeks ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 6 weeks ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 6 weeks ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 7 weeks ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 7 weeks ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 7 weeks ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 7 weeks ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 7 weeks ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 7 weeks ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 7 weeks ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 7 weeks ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 7 weeks ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 7 weeks ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 7 weeks ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 7 weeks ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 29, 2026, 8:00 AM EDT - 2 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 2 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 2 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:00 PM EDT - 2 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 27, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 20, 2026, 9:00 AM EDT - 2 months ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 5:08 AM EDT - 2 months ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:05 AM EDT - 2 months ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

May 18, 2026, 8:00 AM EDT - 2 months ago

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

May 14, 2026, 2:22 PM EDT - 2 months ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

May 13, 2026, 6:45 AM EDT - 2 months ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

May 12, 2026, 8:00 AM EDT - 2 months ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

May 12, 2026, 7:00 AM EDT - 2 months ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

May 5, 2026, 4:09 PM EDT - 3 months ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

CandlesBACKEDSECURITIES Jul. 31 at 12:28 AM

$PFE can we talk about $31? Touchy subject? 😂

0 · Reply

cmhuff Jul. 30 at 11:47 PM

$PFE Sold another put here. Maybe I'm just dumb but I like the dividend and cash flow from selling covered calls

0 · Reply

CandlesBACKEDSECURITIES Jul. 30 at 11:00 PM

$PFE is this going to zero? What the fuck happened to its market cap?

2 · Reply

CandlesBACKEDSECURITIES Jul. 30 at 10:58 PM

$PFE who is the head Pfizer nerd in charge here?

0 · Reply

DidYouReadThis Jul. 30 at 7:52 PM

$NVS $JNJ $PFE $BAYRY

0 · Reply

Stockman824 Jul. 30 at 7:28 PM

0 · Reply

Micheal_Pothead Jul. 30 at 7:12 PM

$PFE can’t wait for them to kill it in the last hour

1 · Reply

nimii Jul. 30 at 6:39 PM

$PFE 😡

0 · Reply

biolover Jul. 30 at 6:23 PM

0 · Reply

inv1ncible Jul. 30 at 5:54 PM

$PFE red on a green day. That makes sense🙄

0 · Reply

Iam4our Jul. 30 at 4:42 PM

$PFE $21? Then bounce

1 · Reply

_Crim_Jamer_ Jul. 30 at 4:37 PM

$PFE market's trying to go up and Albert is trying to go down.

1 · Reply

simonds Jul. 30 at 4:07 PM

$PFE When $23?

2 · Reply

BarkingPuppy Jul. 30 at 3:59 PM

$ELTP $GME $PFE $BTC.X The Number don't Lie. ELTP is Hot. Rumors are based on Facts. Elite Pharmaceuticals reported third-quarter fiscal 2026 results for the three months ended December 31, 2025. Revenue was $31.6 million, up about 120% year-over-year. Income from operations was $9.0 million, up 721%. Net income was $18.6 million. The company attributed the profit increase primarily to sales of newly launched lisdexamfetamine and naltrexone products plus strong growth in Elite-label lines.

0 · Reply

GreenEnergy7B Jul. 30 at 3:49 PM

$ALT Best AUD data seen to date. GLP1 + Glucagon gives patients so many benefits $PFE $NVS $JNJ $BMY

0 · Reply

CandlesBACKEDSECURITIES Jul. 30 at 3:33 PM

$PFE I can sell covered call income against this position and still receive the income from the dividend

1 · Reply

CandlesBACKEDSECURITIES Jul. 30 at 3:32 PM

$PFE I'm here for the dividend

0 · Reply

CandlesBACKEDSECURITIES Jul. 30 at 3:30 PM

$PFE what the fuck is the problem?

0 · Reply

ItsCarRamRod Jul. 30 at 3:24 PM

$PFE this company could cure cancer, fix world hunger, house every homeless on the planet and STILL find a way to be in the red. Great job Bourla

0 · Reply

CandlesBACKEDSECURITIES Jul. 30 at 3:15 PM

$PFE I'm gonna spend the next few days thinking about it and stalking this

0 · Reply

CandlesBACKEDSECURITIES Jul. 30 at 3:15 PM

$PFE I feel like I should put my life savings here

1 · Reply

CandlesBACKEDSECURITIES Jul. 30 at 3:14 PM

$PFE I added 200 shares with the scraps I had left

0 · Reply

Market Cap	143.91B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	8.06
Forward PE	8.35
Profit Margin	12.42%
Debt to Equity Ratio	0.71

Volume	44,954,400
Avg Vol	41,855,883
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	59%
Beta	0.35
Analysts	Sell
Price Target	$28.70